Time to Treatment and Risk Factors for Unsuccessful Treatment Outcomes among People Who Started Second-Line Treatment for Rifampicin-Resistant or Multi-Drug-Resistant Tuberculosis in the Kyrgyz Republic, 2021

Time to Treatment and Risk Factors for Unsuccessful Treatment Outcomes among People Who Started Second-Line Treatment for Rifampicin-Resistant or Multi-Drug-Resistant Tuberculosis in the Kyrgyz Republic, 2021

The Kyrgyz Republic is a high-burden country for rifampicin resistant/multi-drug resistant tuberculosis (RR/MDR-TB). TB control efforts rely on early diagnosis and initiation of people on effective regimens. We studied the interval from diagnosis of RR-TB to starting treatment and risk factors for u...

Full description

Bibliographic Details
Main Authors: Bolot Kyrbashov, Aizat Kulzhabaeva, Abdullaat Kadyrov, Atyrkul Toktogonova, Collins Timire, Srinath Satyanarayana, Kylychbek Istamov
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:Tropical Medicine and Infectious Disease
Subjects:
SORT-IT
RR-TB
Kyrgyzstan
Central Asia
drug resistant tuberculosis
Online Access:https://www.mdpi.com/2414-6366/8/8/407

Internet

https://www.mdpi.com/2414-6366/8/8/407

Similar Items